ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 149 filers reported holding ATARA BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.65 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,174,464 | +4.2% | 793,557 | +13.4% | 0.00% | – |
| Q2 2023 | $1,127,056 | -41.1% | 700,035 | +6.1% | 0.00% | -100.0% |
| Q1 2023 | $1,914,215 | -17.6% | 660,074 | -6.8% | 0.00% | 0.0% |
| Q4 2022 | $2,322,122 | -10.4% | 707,964 | +3.3% | 0.00% | 0.0% |
| Q3 2022 | $2,592,000 | -50.2% | 685,519 | +2.6% | 0.00% | -50.0% |
| Q2 2022 | $5,205,000 | -12.7% | 668,042 | +4.1% | 0.00% | 0.0% |
| Q1 2022 | $5,964,000 | -38.6% | 641,875 | +4.1% | 0.00% | -33.3% |
| Q4 2021 | $9,716,000 | -7.1% | 616,461 | +5.5% | 0.00% | 0.0% |
| Q3 2021 | $10,464,000 | +16.0% | 584,529 | +0.8% | 0.00% | 0.0% |
| Q2 2021 | $9,021,000 | +11.1% | 580,100 | +2.6% | 0.00% | 0.0% |
| Q1 2021 | $8,119,000 | -18.6% | 565,376 | +11.2% | 0.00% | -25.0% |
| Q4 2020 | $9,980,000 | +59.6% | 508,365 | +5.4% | 0.00% | +33.3% |
| Q3 2020 | $6,252,000 | +9.5% | 482,336 | +23.1% | 0.00% | 0.0% |
| Q2 2020 | $5,709,000 | +90.7% | 391,828 | +11.4% | 0.00% | +50.0% |
| Q1 2020 | $2,993,000 | -45.3% | 351,670 | +6.0% | 0.00% | -33.3% |
| Q4 2019 | $5,467,000 | +19.6% | 331,911 | +2.5% | 0.00% | 0.0% |
| Q3 2019 | $4,572,000 | -14.7% | 323,730 | +21.4% | 0.00% | 0.0% |
| Q2 2019 | $5,362,000 | -47.1% | 266,632 | +4.6% | 0.00% | -50.0% |
| Q1 2019 | $10,132,000 | +21.0% | 254,868 | +5.7% | 0.01% | 0.0% |
| Q4 2018 | $8,375,000 | -16.3% | 241,057 | -0.4% | 0.01% | -14.3% |
| Q3 2018 | $10,010,000 | +21.4% | 242,062 | +7.9% | 0.01% | +16.7% |
| Q2 2018 | $8,245,000 | +10.7% | 224,352 | +17.5% | 0.01% | 0.0% |
| Q1 2018 | $7,445,000 | +293.1% | 190,880 | +82.5% | 0.01% | +200.0% |
| Q4 2017 | $1,894,000 | +32.1% | 104,612 | +20.8% | 0.00% | +100.0% |
| Q3 2017 | $1,434,000 | +10.1% | 86,617 | -6.8% | 0.00% | 0.0% |
| Q2 2017 | $1,302,000 | -20.4% | 92,974 | +16.8% | 0.00% | -50.0% |
| Q1 2017 | $1,636,000 | +53.3% | 79,580 | +5.9% | 0.00% | +100.0% |
| Q4 2016 | $1,067,000 | -29.9% | 75,134 | +5.6% | 0.00% | -50.0% |
| Q3 2016 | $1,522,000 | +1.9% | 71,130 | +7.3% | 0.00% | 0.0% |
| Q2 2016 | $1,493,000 | +47.2% | 66,295 | +24.4% | 0.00% | +100.0% |
| Q1 2016 | $1,014,000 | -26.4% | 53,275 | +2.2% | 0.00% | -50.0% |
| Q4 2015 | $1,377,000 | -13.3% | 52,121 | +3.2% | 0.00% | 0.0% |
| Q3 2015 | $1,589,000 | -2.2% | 50,513 | +64.0% | 0.00% | 0.0% |
| Q2 2015 | $1,625,000 | +85.9% | 30,796 | +46.5% | 0.00% | +100.0% |
| Q1 2015 | $874,000 | +160.9% | 21,015 | +67.8% | 0.00% | 0.0% |
| Q4 2014 | $335,000 | – | 12,523 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antipodean Advisors LLC | 1,000,000 | $1,480,000 | 7.58% |
| Redmile Group, LLC | 6,280,813 | $9,295,603 | 0.44% |
| Arctis Global LLC | 397,046 | $587,628 | 0.32% |
| Baupost Group | 9,773,616 | $14,465 | 0.28% |
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 230,000 | $413,400 | 0.24% |
| MAVERICK CAPITAL LTD | 6,290,713 | $9,310,255 | 0.21% |
| 683 Capital Management, LLC | 1,200,000 | $1,776,000 | 0.14% |
| STALEY CAPITAL ADVISERS INC | 1,000,000 | $1,480,000 | 0.08% |
| WASATCH ADVISORS LP | 8,399,229 | $12,430,859 | 0.08% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $777,000 | 0.07% |